DNAL1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNAL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNAL4 Human Pre-designed siRNA Set A contains three designed siRNAs for DNAL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNALI1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNALI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNASE1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNASE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNASE1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNASE1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNASE1L2 Human Pre-designed siRNA Set A contains three designed siRNAs for DNASE1L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNASE1L3 Human Pre-designed siRNA Set A contains three designed siRNAs for DNASE1L3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNASE2 Human Pre-designed siRNA Set A contains three designed siRNAs for DNASE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNCA is a neutral lipid that can be used in the generation of lipid nanoparticles (LNPs). DNCA can be used in nucleic acid delivery[1].

DND1 Human Pre-designed siRNA Set A contains three designed siRNAs for DND1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNER Human Pre-designed siRNA Set A contains three designed siRNAs for DNER gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNLZ Human Pre-designed siRNA Set A contains three designed siRNAs for DNLZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNM1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNM1L Human Pre-designed siRNA Set A contains three designed siRNAs for DNM1L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNM2 Human Pre-designed siRNA Set A contains three designed siRNAs for DNM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNM3 Human Pre-designed siRNA Set A contains three designed siRNAs for DNM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNMBP Human Pre-designed siRNA Set A contains three designed siRNAs for DNMBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNMT/HDAC-IN-1 (Compund 15a) is a dual DNMT and HDAC inhibitor with IC50 values for HDAC1 and HDAC6 are 56.84 nM and 17.39 nM respectively. DNMT/HDAC-IN-1 can induce apoptosis and be used in tumor research.

DNMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dnmt1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dnmt1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Dnmt1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Dnmt1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNMT3A Human Pre-designed siRNA Set A contains three designed siRNAs for DNMT3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNMT3A-IN-2 (compound 1a) is a hydrophthalazinone-based inhibitor of DNA methyltransferase 3A (DNMT3A) (IC50: 14 μM) against S-adenosylmethionine (SAM) has a Ki of 9.16-18.85 μM.[14][1].

DNMT3A-IN-3 is an allosteric DNA methyltransferase 3A (DNMT3A) inhibitor. DNMT3A-IN-3 binds and disrupt protein-protein interactions (PPIs) at the DNMT3A tetramer interface[1].

DNMT3B Human Pre-designed siRNA Set A contains three designed siRNAs for DNMT3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNMT3L Human Pre-designed siRNA Set A contains three designed siRNAs for DNMT3L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNP-INT is a potent photosynthetic electron transport chain (PETC) inhibitor. DNP-INT competently inhibits the oxidation of plastid quinoline by binding to the Q0 site of Cyt-b6f (Kd=1.4 nM), thereby inhibiting electron transfer in plants[1].

DNP-Pro-Leu-Ala-Leu-Trp-Ala-Arg-OH is the substrate for matrix metalloproteinase MMP-1, with a Km of 26.61 μM. DNP-Pro-Leu-Ala-Leu-Trp-Ala-Arg-OH is utilized as fluorescence probe for detecting protein activity[1].

DNPEP Human Pre-designed siRNA Set A contains three designed siRNAs for DNPEP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNPH1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNPH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNSAH-15N2 is 15N labeled DNSAH.

DNTT Human Pre-designed siRNA Set A contains three designed siRNAs for DNTT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNTTIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for DNTTIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DNTTIP2 Human Pre-designed siRNA Set A contains three designed siRNAs for DNTTIP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DO2Ais a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. DO2A can be used for conjugation of peptides and radionuclides.

DO2A-tert-butyl ester is a bifunctional chelator (BFC) that can be used for the coupling of peptides and radionuclides. DO2A-tert-butyl ester can be used in the development of radionuclide imaging tracers[1].

DO2A-tert-butyl ester is a bifunctional chelator (BFC) that can be used for the coupling of peptides and radionuclides. DO2A-tert-butyl ester can be used in the development of radionuclide imaging tracers[1].

DO2A-tert-butyl ester is a bifunctional chelator (BFC) that can be used for the coupling of peptides and radionuclides. DO2A-tert-butyl ester can be used in the development of radionuclide imaging tracers[1].

DO2A-tert-butyl ester is a bifunctional chelator (BFC) that can be used for the coupling of peptides and radionuclides. DO2A-tert-butyl ester can be used in the development of radionuclide imaging tracers[1].

DO3A (trisodium)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. DO3A (trisodium) can be used for conjugation of peptides and radionuclides.

DOC2A Human Pre-designed siRNA Set A contains three designed siRNAs for DOC2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOC2B Human Pre-designed siRNA Set A contains three designed siRNAs for DOC2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Docetaxel (Standard) is the analytical standard of Docetaxel. This product is intended for research and analytical applications. Docetaxel (RP-56976) is a microtubule depolymerization inhibitor, with an IC50 of 0.2 μM. Docetaxel attenuates the effects of bcl-2 and bcl-xL gene expression. Docetaxel arrests the cell cycle at G2/M and leads to cell apoptosis. Docetaxel has anti-cancer activity[1][3].

DOCK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK10 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DOCK11 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.